Shares outstanding increased 0.8%
Shares outstanding changed +0.8% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +0.8% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Capital expenditure changed -35.2% from the comparable as-filed period.
Operating cash-flow margin changed -438 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +34.1% from the comparable as-filed period.
Debt / revenue changed -15191 basis points from the comparable as-filed period.
Current assets changed +13.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed +6.9% from the comparable as-filed period.
Total assets changed +1.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -10.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed -132 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -32 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +8.2% from the comparable as-filed period.
Cost of revenue changed +10.9% from the comparable as-filed period.
Stock-based compensation changed +7.1% from the comparable as-filed period.
Free-cash-flow margin changed -42 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed -30 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Cash / debt changed +53 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital changed -0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +0.8% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Revenue changed +11.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -40.9% from the comparable as-filed period.
Debt / revenue changed -11195 basis points from the comparable as-filed period.
Free-cash-flow margin changed +730 basis points from the comparable as-filed period.
Operating cash-flow margin changed +336 basis points from the comparable as-filed period.
Gross profit changed +19.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Noncurrent long-term debt changed -12.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed -6.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -126 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -26 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed +4.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Selling, general & administrative changed +9.9% from the comparable as-filed period.
Research & development changed -1.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash / debt changed +78 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -1.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Cost of revenue changed +5.1% from the comparable as-filed period.
Working capital changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current ratio changed -7.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital / assets changed +18 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory changed +1.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Total assets changed -0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.